Mark A. Wisniewski MS, MBA

Mark Wisniewski is the Senior Director of Biopharmaceuticals.  He is responsible for the life science and biopharma intellectual property developed at UCLA, including managing licensing and marketing staff, financial management of the portfolio and outreach to inventors and industry.  His career spanned multiple roles in biotech management, entrepreneurship and product commercialization in both start-up to Fortune 100 companies.  Prior to his role at UCLA TDG, Mark was the Head of Special Projects at Prolacta Bioscience, a producer of human milk nutritional products for premature infants in the neonatal intensive care unit, leading the strategic planning and business development functions. He was also a Principal Advisor to the National Institutes of Health and National Cancer Institute’s Commercialization Accelerator Programs which provides business strategy, product commercialization, fund raising and strategic partnership guidance to hundreds of early stage biotech and life science companies. Mark began his career at Baxter Healthcare where he held positions in business development, strategic planning, marketing and R&D.  Mark received his MBA from the UCLA Anderson School of Management and his Masters of Immunology and Microbiology at the UCLA School of Medicine.